Contact
searchSearch
HMP Global

December 2012 - FRMC

Biomarker Changes in Alzheimer Disease
12/17/2012
Kevin L. Carter
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the...
12/17/2012
First Report Managed Care
Inhibition of HIV-1 Disease Progression
12/17/2012
Kevin L. Carter
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses...
12/17/2012
First Report Managed Care
Administration of Telaprevir Twice or 3 Times Daily
12/17/2012
Tim Casey
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C...
12/17/2012
First Report Managed Care
Boceprevir Pharmacokinetics
12/17/2012
Tim Casey
Boston—An analysis of clinical trials found that co-infected patients had a reduction in boceprevir exposure compared with mono-infected patients with hepatitis C. The authors noted the difference likely occurred because of an interaction...
Boston—An analysis of clinical trials found that co-infected patients had a reduction in boceprevir exposure compared with mono-infected patients with hepatitis C. The authors noted the difference likely occurred because of an interaction...
Boston—An analysis of clinical...
12/17/2012
First Report Managed Care
Conference Insider
Session Discusses Effective Insomnia Management
12/17/2012
Eileen Koutnik-Fotopoulos
San Diego—Insomnia is prevalent in the general population and quite common among people with mental health disorders. Approximately 50 to 70 million Americans suffer from chronic sleep disorders that adversely affect daily functioning,...
San Diego—Insomnia is prevalent in the general population and quite common among people with mental health disorders. Approximately 50 to 70 million Americans suffer from chronic sleep disorders that adversely affect daily functioning,...
San Diego—Insomnia is prevalent...
12/17/2012
First Report Managed Care
Hospitalization and Costs Lower with Aripiprazole
12/17/2012
Eileen Koutnik-Fotopoulos
San Diego—A retrospective cohort analysis of medical and pharmacy claims data from 24 state Medicaid plans found that schizophrenia patients newly treated with the atypical antipsychotic (AA) aripiprazole had lower hospitalization rates and...
San Diego—A retrospective cohort analysis of medical and pharmacy claims data from 24 state Medicaid plans found that schizophrenia patients newly treated with the atypical antipsychotic (AA) aripiprazole had lower hospitalization rates and...
San Diego—A retrospective cohort...
12/17/2012
First Report Managed Care
Vilazodone Well Tolerated in Treatment of MDD
12/17/2012
Eileen Koutnik-Fotopoulos
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal...
12/17/2012
First Report Managed Care
Conference Insider
Combination Therapy for ADHD Shows Promise
12/17/2012
Eileen Koutnik-Fotopoulos
San Diego—Combination therapy has been used informally in mental health, but new evidence is emerging that combination therapy is safe and effective for difficult and treatment-resistant cases of attention-deficit hyperactivity disorder...
San Diego—Combination therapy has been used informally in mental health, but new evidence is emerging that combination therapy is safe and effective for difficult and treatment-resistant cases of attention-deficit hyperactivity disorder...
San Diego—Combination therapy...
12/17/2012
First Report Managed Care
Benefits of Wellness Programs, On-Site Care Services
12/17/2012
Tim Casey
Las Vegas—Research presented during a session at the Fall Managed Care Forum showed that employers, employees, and health plans can benefit from implementing wellness programs, managing chronic conditions such as diabetes, and having on-site...
Las Vegas—Research presented during a session at the Fall Managed Care Forum showed that employers, employees, and health plans can benefit from implementing wellness programs, managing chronic conditions such as diabetes, and having on-site...
Las Vegas—Research presented...
12/17/2012
First Report Managed Care
Biologic DMARDs for Rheumatoid Arthritis
12/17/2012
Tim Casey
Las Vegas—Soon after patients are diagnosed with rheumatoid arthritis (RA), they experience symptoms, and, within 2 years, they have a moderate loss of function that can contribute to health problems, lost work time, and other issues. To...
Las Vegas—Soon after patients are diagnosed with rheumatoid arthritis (RA), they experience symptoms, and, within 2 years, they have a moderate loss of function that can contribute to health problems, lost work time, and other issues. To...
Las Vegas—Soon after patients...
12/17/2012
First Report Managed Care
Results from the 2012 Eisai Oncology Digest
12/17/2012
Tim Casey
Las Vegas—Regardless of the rising costs of oncology drugs, health insurers, the federal government, and other payers are increasingly likely to cover oncology medications, according to a recent survey. The 2012 Eisai Oncology Digest asked...
Las Vegas—Regardless of the rising costs of oncology drugs, health insurers, the federal government, and other payers are increasingly likely to cover oncology medications, according to a recent survey. The 2012 Eisai Oncology Digest asked...
Las Vegas—Regardless of the...
12/17/2012
First Report Managed Care
Challenges and Costs Associated with Major Depression
12/17/2012
Tim Casey
Las Vegas—Major depression disorder (MDD) is the most common psychiatric disorder in the United States, but few Americans with MDD receive optimum treatment, according to Ken Hopper, MD, executive consultant at BHM Healthcare Solutions, a...
Las Vegas—Major depression disorder (MDD) is the most common psychiatric disorder in the United States, but few Americans with MDD receive optimum treatment, according to Ken Hopper, MD, executive consultant at BHM Healthcare Solutions, a...
Las Vegas—Major depression...
12/17/2012
First Report Managed Care
Therapeutic Options for Chronic Pain
12/17/2012
Tim Casey
Las Vegas—Treating patients with chronic pain can cause difficulties since there are both physiological components and psychological issues, which can lead to irritability or depression and make the condition even worse.
Las Vegas—Treating patients with chronic pain can cause difficulties since there are both physiological components and psychological issues, which can lead to irritability or depression and make the condition even worse.
Las Vegas—Treating patients with...
12/17/2012
First Report Managed Care
ACA Preventive Benefit and Coverage of Colonoscopies
12/17/2012
Tori Socha
The Patient Protection and Affordable Care Act (ACA) includes provisions that require private health insurance companies to cover recommended preventive services with no patient cost-sharing, including copayments and deductibles. The...
The Patient Protection and Affordable Care Act (ACA) includes provisions that require private health insurance companies to cover recommended preventive services with no patient cost-sharing, including copayments and deductibles. The...
The Patient Protection and...
12/17/2012
First Report Managed Care
Changes in Expenditures for Asthma Medications in Adults
12/17/2012
Tori Socha
The prevalence of asthma has increased across all age groups over the past 10 years. Asthma is a chronic inflammatory disorder of the airways and adverse health outcomes can result when it is poorly controlled. Guidelines for the management...
The prevalence of asthma has increased across all age groups over the past 10 years. Asthma is a chronic inflammatory disorder of the airways and adverse health outcomes can result when it is poorly controlled. Guidelines for the management...
The prevalence of asthma has...
12/17/2012
First Report Managed Care
Trends in Medication Use among Adults with Asthma
12/17/2012
Tori Socha
In the years between 1998 and 2009, the number of adults reporting treatment for asthma nearly doubled from 5.5 million (2.7% of US adults ≥18 years of age) in 1998 to 10.3 million (4.5%). Asthma is a chronic respiratory disease that causes...
In the years between 1998 and 2009, the number of adults reporting treatment for asthma nearly doubled from 5.5 million (2.7% of US adults ≥18 years of age) in 1998 to 10.3 million (4.5%). Asthma is a chronic respiratory disease that causes...
In the years between 1998 and...
12/17/2012
First Report Managed Care
Bariatric Surgery and Prevention of Type 2 Diabetes
12/17/2012
Tori Socha
Previous studies have demonstrated associations between obesity and type 2 diabetes, and between changes in body weight and incident type 2 diabetes. There is also an association between the increase worldwide in obesity and the increased...
Previous studies have demonstrated associations between obesity and type 2 diabetes, and between changes in body weight and incident type 2 diabetes. There is also an association between the increase worldwide in obesity and the increased...
Previous studies have...
12/17/2012
First Report Managed Care
Markers for Improved Evaluation of Intermediate Heart Risk
12/17/2012
Eileen Koutnik-Fotopoulos
An analysis of 6 of the most novel risk factors for improvement in cardiovascular risk assessment found 4 markers that were independent predictors of incident coronary heart disease (CHD)/cardiovascular disease (CVD) in intermediate-risk...
An analysis of 6 of the most novel risk factors for improvement in cardiovascular risk assessment found 4 markers that were independent predictors of incident coronary heart disease (CHD)/cardiovascular disease (CVD) in intermediate-risk...
An analysis of 6 of the most...
12/17/2012
First Report Managed Care
PSA Screening and Effects on Quality of Life
12/17/2012
Alice Brindle
Benefits of screening for prostate cancer include reduction in disease-related mortality, increase in the number of life-years gained, and a reduction in the rate of advanced disease. However, prostate-specific antigen (PSA) screening is...
Benefits of screening for prostate cancer include reduction in disease-related mortality, increase in the number of life-years gained, and a reduction in the rate of advanced disease. However, prostate-specific antigen (PSA) screening is...
Benefits of screening for...
12/17/2012
First Report Managed Care
Tofacitinib Monotherapy for RA versus Risk of Adverse Events
12/17/2012
Mary Beth Nierengarten
Results of a phase 3, double-blind, placebo-controlled study [N Engl J Med. 2012;367(6):495-507] show that tofacitinib monotherapy is associated with a reduction in signs and symptoms of rheumatoid arthritis (RA) and improvement in physical...
Results of a phase 3, double-blind, placebo-controlled study [N Engl J Med. 2012;367(6):495-507] show that tofacitinib monotherapy is associated with a reduction in signs and symptoms of rheumatoid arthritis (RA) and improvement in physical...
Results of a phase 3,...
12/17/2012
First Report Managed Care
Cardiogenic Shock Complicating Acute Myocardial Infarction
12/17/2012
Mary Beth Nierengarten
Results of a randomized, prospective, open-label, multicenter trial [N Engl J Med. 2012; DOI:10.1056/NEJMoa1208410] showed no significant reduction in 30-day mortality in patients with cardiogenic shock complicating acute myocardial...
Results of a randomized, prospective, open-label, multicenter trial [N Engl J Med. 2012; DOI:10.1056/NEJMoa1208410] showed no significant reduction in 30-day mortality in patients with cardiogenic shock complicating acute myocardial...
Results of a randomized,...
12/17/2012
First Report Managed Care
Older Patients with Mantle-Cell Lymphoma
12/17/2012
Kevin L. Carter
The long-term prognosis for older patients with mantle-cell lymphoma is poor. Only a minority of patients have a complete remission, and relapse or progression usually occurs within 2 to 3 years, resulting in an overall survival of <5...
The long-term prognosis for older patients with mantle-cell lymphoma is poor. Only a minority of patients have a complete remission, and relapse or progression usually occurs within 2 to 3 years, resulting in an overall survival of <5...
The long-term prognosis for...
12/17/2012
First Report Managed Care
JAK Inhibitor Shows Improvement in Moderate-to-Severe Ulcerative Colitis
12/17/2012
Mary Mihalovic
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative...
12/17/2012
First Report Managed Care
Lipid-Modifying Therapies Lower Risk of Pancreatitis
12/17/2012
Tori Socha
The intensity of pancreatitis can range from a mild, self-limiting episode to a severe or even fatal event. There have been case reports and studies suggesting that pancreatitis may be caused by statin use. According to researchers, few of...
The intensity of pancreatitis can range from a mild, self-limiting episode to a severe or even fatal event. There have been case reports and studies suggesting that pancreatitis may be caused by statin use. According to researchers, few of...
The intensity of pancreatitis...
12/17/2012
First Report Managed Care
News
An Algorithm to Detect Multiple Sclerosis Relapses
12/17/2012
Tori Socha
Multiple sclerosis (MS) is a multi-faceted autoimmune demyelinating disorder affecting >400,000 individuals in the United States. Prevention of relapses in patients with MS is a primary goal of MS therapy. Confirmation of a relapse in...
Multiple sclerosis (MS) is a multi-faceted autoimmune demyelinating disorder affecting >400,000 individuals in the United States. Prevention of relapses in patients with MS is a primary goal of MS therapy. Confirmation of a relapse in...
Multiple sclerosis (MS) is a...
12/17/2012
First Report Managed Care
News
Interferon Beta and Disability in Patients with RRMS
12/17/2012
Tori Socha
Multiple sclerosis (MS), a chronic condition that usually affects people in the prime of their lives, is characterized by clinical progression over time manifested by the accumulation of disability. The most widely prescribed...
Multiple sclerosis (MS), a chronic condition that usually affects people in the prime of their lives, is characterized by clinical progression over time manifested by the accumulation of disability. The most widely prescribed...
Multiple sclerosis (MS), a...
12/17/2012
First Report Managed Care
News
Cost-Effectiveness of MS Therapy
12/17/2012
Tori Socha
The most common disabling neurologic disease among adults 18 to 60 years of age is multiple sclerosis (MS). Disease-modifying therapies (DMTs) are the gold standard of disease management for MS, with the goal of preventing or delaying...
The most common disabling neurologic disease among adults 18 to 60 years of age is multiple sclerosis (MS). Disease-modifying therapies (DMTs) are the gold standard of disease management for MS, with the goal of preventing or delaying...
The most common disabling...
12/17/2012
First Report Managed Care
News
Oral BG-12 or Glatiramer Acetate for Multiple Sclerosis
12/17/2012
Tori Socha
Parenteral agents (interferon beta and glatiramer acetate) are common treatments for multiple sclerosis (MS), a chronic demyelinating and neurodegenerative disease of the central nervous system. According to researchers, oxidative stress and...
Parenteral agents (interferon beta and glatiramer acetate) are common treatments for multiple sclerosis (MS), a chronic demyelinating and neurodegenerative disease of the central nervous system. According to researchers, oxidative stress and...
Parenteral agents (interferon...
12/17/2012
First Report Managed Care
Healthcare Reform and Patients with HIV
12/17/2012
Tori Socha
Ensuring that all individuals in the United States who are living with HIV have access to quality healthcare has been a challenge since the onset of the epidemic. The Patient Protection and Affordable Care Act (ACA) is designed to expand...
Ensuring that all individuals in the United States who are living with HIV have access to quality healthcare has been a challenge since the onset of the epidemic. The Patient Protection and Affordable Care Act (ACA) is designed to expand...
Ensuring that all individuals in...
12/17/2012
First Report Managed Care
Conference Insider
Keys to Success in Healthcare
12/17/2012
Tim Casey
Las Vegas—It is no secret healthcare providers are facing challenges. Hospitals and physicians have struggled with reimbursement and profitability. They are also concerned with selected provisions of the Patient Protection and Affordable Care...
Las Vegas—It is no secret healthcare providers are facing challenges. Hospitals and physicians have struggled with reimbursement and profitability. They are also concerned with selected provisions of the Patient Protection and Affordable Care...
Las Vegas—It is no secret...
12/17/2012
First Report Managed Care
Conference Insider
The ACA and Clinically Integrated Organizations
12/17/2012
Tim Casey
Las Vegas—For the past 15 years, federal government legislation has helped transform the healthcare industry. In 1997, the Balanced Budget Act established the Medicare sustainable growth rate, which has led to a $300 billion underfunded...
Las Vegas—For the past 15 years, federal government legislation has helped transform the healthcare industry. In 1997, the Balanced Budget Act established the Medicare sustainable growth rate, which has led to a $300 billion underfunded...
Las Vegas—For the past 15 years,...
12/17/2012
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Who Will Benefit Under the Medicare Part D Out-of-Pocket Spending Cap?
02/27/2024
Dean Celia
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part...
02/27/2024
First Report Managed Care
News
The Impact of Inhibitors on Surgical Management in Patients With Hemophilia
04/04/2024
Hannah Musick
The development of inhibitors in patients with hemophilia poses challenges for achieving perioperative hemostasis and may result in complications and deviations from the surgical plan, highlighting the need for strategies to address inhibitor...
The development of inhibitors in patients with hemophilia poses challenges for achieving perioperative hemostasis and may result in complications and deviations from the surgical plan, highlighting the need for strategies to address inhibitor...
The development of inhibitors in...
04/04/2024
First Report Managed Care
Conference Coverage
Expanding Pharmacists’ Role in Providing Clinical Care: Addressing Public Health Challenges
05/02/2024
Danielle Sposato
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various...
05/02/2024
First Report Managed Care
Managed Care Q&A
Prioritizing Patient Voices in Drug Development and Coverage
05/27/2024
In this interview, guest experts discuss the importance of incorporating patient voices into health care decision-making, highlighting opportunities for collaboration and enhancement in drug development and patient coverage.
In this interview, guest experts discuss the importance of incorporating patient voices into health care decision-making, highlighting opportunities for collaboration and enhancement in drug development and patient coverage.
In this interview, guest experts...
05/27/2024
First Report Managed Care
Blog
The Clash Over Medicare: Key Lawsuits Challenging the IRA’s Drug Negotiation Provisions
07/11/2024
Katie Hayes, MJ
The IRA has spawned a series of lawsuits from pharmaceutical companies. Here, we provide the latest status updates on several of them.
The IRA has spawned a series of lawsuits from pharmaceutical companies. Here, we provide the latest status updates on several of them.
The IRA has spawned a series of...
07/11/2024
First Report Managed Care

December 2012 Volume 9 Issue 12

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use